Prognostic value of major extracranial injury in traumatic brain injury: an individual patient data meta-analysis in 39,274 patients

Author(s): van Leeuwen N, Lingsma HF, Perel P, Lecky F, Roozenbeek B, et al.

Abstract

Background:Major extracranial injury (MEI) is common in traumatic brain injury (TBI) patients, but the effect on outcome is controversial.

Objective:To assess the prognostic value of MEI on mortality after TBI in an individual patient data meta-analysis of 3 observational TBI studies (International Mission on Prognosis and Clinical Trial Design in TBI [IMPACT]), a randomized controlled trial (Corticosteroid Randomization After Significant Head Injury [CRASH]), and a trauma registry (Trauma Audit and Research Network [TARN]).

Methods:MEI (extracranial injury with an Abbreviated Injury Scale ≥ 3 or requiring hospital admission) was related to mortality with logistic regression analysis, adjusted for age, Glasgow Coma Scale motor score, and pupil reactivity and stratified by TBI severity. We pooled odds ratios (ORs) with random-effects meta-analysis.

Results:We included 39,274 patients. Mortality was 25%, and 32% had MEI. MEI was a strong predictor for mortality in TARN, with adjusted odds ratios of 2.81 (95% confidence interval [CI], 2.44-3.23) in mild, 2.18 (95% CI, 1.80-2.65) in moderate, and 2.14 (95% CI, 1.95-2.35) in severe TBI patients. The prognostic effect was smaller in IMPACT and CRASH, with pooled adjusted odds ratios of 2.14 (95% CI, 0.93-4.91) in mild, 1.46 (95% CI, 1.14-1.85) in moderate, and 1.18 (95% CI, 1.03-1.55) in severe TBI. When patients who died within 6 hours after injury were excluded from TARN, the effect of MEI was comparable with IMPACT and CRASH.

Conclusion:MEI is an important prognostic factor for mortality in TBI patients. However, the effect varies by population, which explains the controversy in the literature. The strength of the effect is smaller in patients with more severe brain injury and depends on time of inclusion in a study.

Similar Articles

Antisaccades and remembered saccades in mild traumatic brain injury

Author(s): Crevits L, Hanse MC, Tummers P, Van Maele G

Subacute to chronic mild traumatic brain injury

Author(s): Mott TF, McConnon ML, Rieger BP

Meta-analysis of APOE4 allele and outcome after traumatic brain injury

Author(s): Zhou W, Xu D, Peng X, Zhang Q, Jia J, et al.

Traumatic brain injuries evaluated in U

Author(s): Jager TE, Weiss HB, Coben JH, Pepe PE

A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury

Author(s): Shenton ME, Hamoda HM, Schneiderman JS, Bouix S, Pasternak O, et al.

The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury

Author(s): Büki A, Siman R, Trojanowski JQ, Povlishock JT

Neuronal cytoskeletal changes are an early consequence of repetitive head injury

Author(s): Geddes JF, Vowles GH, Nicoll JA, Révész T

mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury

Author(s): Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, et al.

Nimodipine attenuates lipid peroxidation during the acute phase of head trauma in rats

Author(s): Ercan M, Inci S, Kilinc K, Palaoglu S, Aypar U